Bruce Colwill serves as Executive at InMed Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Bruce Colwill has executed 2 insider transactions totaling $14.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 24, 2022 involved purchasing 5,000 shares valued at $5.5K.
Bruce Colwill currently holds 11,515 shares of InMed Pharmaceuticals Inc. (INM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bruce Colwill has been a net buyer of INM stock. They have purchased $14.3K and sold $0 worth of shares.
Bruce Colwill's most recent insider trade was on Jan 24, 2022, when they purchased 5,000 shares at $1.09 per share.
Get notified when new Form 4 filings are submitted
| $1.77 |
| Discretionary |